OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2021
(4)
2022
(3)
2020
(3)
2018
(2)
2017
(2)
2011
(2)
2025
(1)
2024
(1)
2023
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications.
Not available
S-EPMC7396525
|
biostudies-literature
Cite
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.
Not available
S-EPMC5814167
|
biostudies-literature
Cite
Assessing Determinants of Response to PARP Inhibition in Germline <i>ATM</i> Mutant Melanoma.
Not available
S-EPMC12346925
|
biostudies-literature
Cite
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry.
Not available
S-EPMC5352383
|
biostudies-literature
Cite
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Not available
S-EPMC10002464
|
biostudies-literature
Cite
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.
Not available
S-EPMC9496779
|
biostudies-literature
Cite
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Not available
S-EPMC11097509
|
biostudies-literature
Cite
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.
Not available
S-EPMC9434136
|
biostudies-literature
Cite
Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD,
ATM, BAP1,
and
POT1
.
Not available
S-EPMC7226507
|
biostudies-literature
Cite
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.
Not available
S-EPMC8553617
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets